Navigation Links
William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionix's Strategic Expansion in the US Market
Date:11/3/2008

CLEVELAND, Ohio and LOD, Israel, November 3 /PRNewswire/ -- Simbionix USA Corporation (Simbionix), a developer of medical simulators and hands-on curriculum for training medical professionals, today announced that William E. Lewandowski will join the company as the US Marketing Director on November 10th, 2008. Gary Zamler, Simbionix CEO stated, "Over the past two consecutive years, Simbionix has enjoyed double digit revenue growth in both our International and Domestic markets. We are particularly pleased to have someone of Bill's caliber join our expanding US organization to increase the momentum as we rollout new and exciting products such as 'PROcedure Rehearsal Studio' the Simulation Industry's first patient specific technology."

Bill brings to Simbionix a unique background with over 20 years of experience in the business of training and simulation in the aviation, defense and medical industries. For the last 3 years, Bill has been an independent consultant in the acquisition, development, use and validation of simulation and training devices to a wide range of clients in Asia, Europe, and the United States . Inbal Mazor, Simbionix Corporate VP Marketing stated, " Bill's experience and knowledge will assist us to maintain our market leadership position within the medical education and simulation markets. We are pleased to have Bill join Simbionix and lead our US marketing efforts."

In addition to his consultant work, Bill has held key positions in the training and simulation industry. Bill held the position of Vice President for Simulation Systems, and later Business Development, for a producer of medical simulations. He oversaw the development of medical simulation products and established development contracts with leading medical device companies. At FlightSafety International (a major international producer of flight simulators and commercial aviation training), Bill managed a division that developed Federal Aviation Administration (FAA) certified training products, which included instructor-led courseware, eLearning, and non-motion simulations. He was also instrumental in winning curriculum development contracts with major airplane manufacturers in Brazil , Canada , France , Israel , and the United States .

Bill rounds out his business experience with solid academic credentials. He holds a Master of Science (MS) degree in Instructional and Performance Technology from Boise State University , Idaho , and he is currently pursuing a research Doctor of Philosophy (PhD) degree in Health Science at the University of Liverpool, UK. He has published and presented in professional medical society venues and has served on publication peer review committees for instructional design and medical societies. Bill is a member of the American Society for Training and Development, the International Society for Performance Improvement and the Society for Simulation in Healthcare.

Contact:

Gary Zamler,

CEO,

Simbionix, USA Corporation,,

Tel: +1-216-229-2040,

Fax: +1-216-229-2070,

Email: gary@simbionix.com .


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response
2. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
3. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
4. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
5. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
6. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
7. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
8. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
9. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
10. Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference
11. Alexion to Present at the William Blair 28th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
Breaking Biology Technology:
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):